Focus: XS Innovations is a Netherlands-based biotechnology company specializing in vascular access devices for cardiovascular applications. The company is currently in active hiring mode with 17 open positions, suggesting early-stage growth.
Profile data last refreshed 12m ago · AI intelligence enriched 1w ago
XS Innovations represents a high-risk, high-reward early-stage opportunity suitable only for professionals comfortable with uncertainty and seeking hands-on device development experience.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for XS Innovations
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from XS Innovations's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo